A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901

@article{Maruyama2013AFT,
  title={A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901},
  author={Riichiroh Maruyama and Noriyuki Ebi and Junji Kishimoto and Masato Kato and Tokujiro Yano and Yoshinori Nagamatsu and Shuichi Tsukamoto and Shinji Akamine and Sho Saeki and Yukito Ichinose},
  journal={International Journal of Clinical Oncology},
  year={2013},
  volume={19},
  pages={57-62}
}
The present study was designed to determine whether adjuvant chemotherapy with S-1 after surgical resection is feasible in elderly patients with non-small cell lung cancer (NSCLC), using a multi-institutional trial. From July 2009 to July 2011, 25 patients received the following regimen: 2 weeks of administration and 1 week of withdrawal of S-1 at 50–100 mg/body per day in an outpatient setting. The primary endpoint of this trial was the completion rate of eight cycles. The completion rate of… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Similar Papers

Loading similar papers…